Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hiroshi Wada
Institutions:
Osaka Hospital,
Japan Community Healthcare Organization,
Osaka International Cancer Institute
Observed institutions:
Osaka Hospital,
Japan Community Healthcare Organization,
Osaka International Cancer Institute
ORCID:
0000-0003-0510-5744
Observed ORCID:
0000-0003-0510-5744
OpenAlex ID:
A5032551332
Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer
2025
·
Yoshitomo Yanagimoto
, Kazuyoshi Yamamoto
, et al.
·
Japanese Journal of Clinical Oncology
·
21
Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomes
2025
·
Yuki Ushimaru
, Takeshi Omori
, et al.
·
Gastric Cancer
·
16
Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin
2025
·
Takahito Sugase
, Takashi Kanemura
, et al.
·
Annals of Surgical Oncology
·
15
A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer
2024
·
Hirofumi Akita
, Yosuke Mukai
, et al.
·
Surgery
·
13
Prognostic impact of dysphagia scores in patients with advanced resectable esophageal cancer who underwent radical esophagectomy after preoperative treatment
2024
·
Takahito Sugase
, Takashi Kanemura
, et al.
·
Journal of Gastrointestinal Surgery
·
10
Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy
2023
·
Takahito Sugase
, Takashi Kanemura
, et al.
·
Oncology
·
10
Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer
2022
·
Takahito Sugase
, Keijiro Sugimura
, et al.
·
Oncology
·
10
Three-year follow-up outcomes of postoperative quality of life from a randomized controlled trial comparing multi-port versus single-port laparoscopic distal gastrectomy
2024
·
Kohei Fujita
, Takeshi Omori
, et al.
·
Surgical Endoscopy
·
6
PDF
Efficacy of the U‐shaped flap technique in preventing reflux after minimally invasive proximal gastrectomy for proximal gastric and esophagogastric junction cancer
2024
·
Takeshi Omori
, Hisashi Hara
, et al.
·
Annals of Gastroenterological Surgery
·
6
Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy
2023
·
Hidenori Takahashi
, Hirofumi Akita
, et al.
·
Annals of Surgery
·
6
Safety and short-term outcomes of adjuvant nivolumab therapy at 480 mg dose every four weeks in resected esophageal cancer: a prospective cohort study
2025
·
Takahito Sugase
, Takashi Kanemura
, et al.
·
Esophagus
·
4
Prognostic impact of nodal status and lymphovascular invasion in patients undergoing neoadjuvant chemotherapy for esophageal squamous cell carcinoma
2024
·
Hiroshi Miyata
, Keijirou Sugimura
, et al.
·
Diseases of the Esophagus
·
3
Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study)
2023
·
Shogo Kobayashi
, Hiroshi Wada
, et al.
·
Oncology
·
3
ASO Visual Abstract: Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin
2025
·
Takahito Sugase
, Takashi Kanemura
, et al.
·
Annals of Surgical Oncology
·
2
Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma
2025
·
Takahito Sugase
, Takashi Kanemura
, et al.
·
Diseases of the Esophagus
·
2
Short- and long-term outcomes of robotic versus conventional laparoscopic surgery for middle or lower rectal cancer: a propensity score-matched analysis
2025
·
Toshinori Sueda
, Masayoshi Yasui
, et al.
·
International Journal of Colorectal Disease
·
1
PDF
Prognostic impact of aberrant right hepatic artery involvement in patients with pancreatic cancer: A multicenter retrospective cohort study
2024
·
Hiroki Ueda
, Hidenori Takahashi
, et al.
·
Journal of Surgical Oncology
·
1
A case of gallbladder metastasis from nasal mucosal melanoma with noteworthy endoscopic ultrasonography findings
2023
·
Yugo Kai
, Kenji Ikezawa
, et al.
·
Journal of Medical Ultrasonics
·
1
Comparison of adverse events and outcomes between patients with and without drain insertion after laparoscopic liver resection: A randomized controlled trial in Japan (CSGO- HBP-016)
2026
·
Yoshiaki Ohmura
, Yutaka Takeda
, et al.
·
Research Square
Enoxaparin attenuates early postoperative elevation of D-dimer following hepatobiliary and pancreatic surgery
2026
·
Shu Aoyama
, Takehiro Noda
, et al.
·
Langenbeck s Archives of Surgery
Current status and short-term results regarding frailty in patients undergoing gastrointestinal cancer resection in Japan: a retrospective cohort study
2026
·
Asuka Yasueda
, Junichi Nishimura
, et al.
·
한국정맥경장영양학회지
PDF
Study protocol: A randomized controlled trial of chemoradiotherapy versus chemotherapy as neoadjuvant therapy for resectable pancreatic cancer (CSGO-HBP-027)
2026
·
Yoshito Tomimaru
, Hirofumi Akita
, et al.
·
PLoS ONE
PDF
Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2026
·
Tasuku Nakabori
, Masaki Kawabata
, et al.
·
Cancer Medicine
PDF
[Porto-Biliary-Enteric Fistula after Portal Vein Stenting for Stenosis Following Pancreaticoduodenectomy-A Case Report].
2025
·
Yosuke Mukai
, Masahiko Kubo
, et al.
·
PubMed
Reply to letter to editor by yinfang Wu, MM about our manuscript, “A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer”
2025
·
Hirofumi Akita
, Yosuke Mukai
, et al.
·
Surgery
Show more works
View as search
Works count:
27
Citation count:
130
H-index:
7
I10-index:
7
Year
Topic
Type